The high resolution and scale that single cell analysis provides is revolutionizing drug discovery and development by introducing comparative, longitudinal, and causal information that transforms our ability to understand biology and disease. Pharmaceutical and biotech companies are harnessing the power of 10x Genomics’ suite of solutions to identify and sustain a pipeline of novel targets, and accelerate key promising assets through development. These cutting edge technologies play an integral role in biomarker discovery, resolve complex therapeutic mechanism(s) of action, and further our understanding of how therapies can be deployed to minimize resistance and separate responders versus non-responders.
Read Now